Evolus (EOLS) Current Assets (2017 - 2026)
Evolus' Current Assets was $167.54 million in Q2 2026, up 15.6% from $144.97 million a year earlier and up 20.6% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Evolus came in at $142.92 million, down 5.6% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- In earlier years, Current Assets was $151.34 million in FY2024 (+34.6%), $112.42 million in FY2023 (+11.5%), $100.8 million in FY2022 (-43.6%) and $178.8 million in FY2021 (+40.1%).
- The Q2 2026 figure marks the highest quarterly Current Assets since Q4 2021.
- Compared with a year earlier, Current Assets was higher in four of the last eight quarters, with growth averaging 10.3%.
- The best year-over-year quarter for Current Assets over five years was Q1 2022 (growth of 83.9%); the worst was Q4 2022 (a decline of 43.6%).
- Per Business Quant data, EOLS's Current Assets in the three quarters before Q2 2026 was $138.92 million (Q1 2026), $142.92 million (Q4 2025) and $134.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Evolus | 525.47 Mn | 333.16 Mn | 57.18 Mn | 167.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167.54 Mn |
| Mar 31, 2026 | 138.92 Mn |
| Dec 31, 2025 | 142.92 Mn |
| Sep 30, 2025 | 134.89 Mn |
| Jun 30, 2025 | 144.97 Mn |
| Mar 31, 2025 | 131.72 Mn |
| Dec 31, 2024 | 151.34 Mn |
| Sep 30, 2024 | 150.36 Mn |
| Jun 30, 2024 | 158.13 Mn |
| Mar 31, 2024 | 150.27 Mn |
| Dec 31, 2023 | 112.42 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 96.46 Mn |
| Mar 31, 2023 | 84.09 Mn |
| Dec 31, 2022 | 100.80 Mn |
| Sep 30, 2022 | 115.95 Mn |
| Jun 30, 2022 | 133.95 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 178.80 Mn |
| Sep 30, 2021 | 138.34 Mn |
API Access
Evolus Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();